Status:

UNKNOWN

Effects of Cathodal tDCS on Executive Functions in Autism

Lead Sponsor:

Centre Hospitalier du Rouvray

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

20-50 years

Phase:

NA

Brief Summary

It's an interventional, prospective and monocentric pilot study concerning adult patients with autism without mental retardation. The primary outcome is to assess the effects of cathodal transcranial...

Detailed Description

The patients concerned by the study are aged 20 to 50 years old. They meet ICD-10 criteria for autism without mental retardation or Asperger syndrome and they have adaptive capacity and autonomy compl...

Eligibility Criteria

Inclusion

  • With ICD-10 criteria for autism without mental retardation or Asperger syndrome;
  • Patient with adaptive capacity and autonomy complaints.
  • Patients with stable treatments for at least 4 weeks prior and during all the study;
  • Patient with no history of tDCS;
  • Patients affiliated to a social security system;
  • Patients who give their informed written consents;
  • For women of childbearing age: effective contraception; required (estrogen and progestogen or intra-uterine device or tubal ligation) for at least 1 month before starting treatment (a negative pregnancy test has been obtained).

Exclusion

  • Skin disease, dementia, history of epileptic seizures, brain tumor or metallic implants/implanted electrical devices.
  • Patients who followed à cognitive remediation program during the last 6 months;
  • Subjects currently treated with magnetic or electrical stimulation techniques (e.g.: transcutaneous or root stimulation).
  • Women of childbearing age with no adequate contraception, pregnant or lactating women;
  • Patients participating or having participated in an interventional clinical trial within 30 days prior to the inclusion visit;
  • Subjects who are deprived of their liberty by decision of a judicial or administrative authority.

Key Trial Info

Start Date :

December 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2017

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT03235596

Start Date

December 1 2016

End Date

August 1 2017

Last Update

August 1 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier du Rouvray

Sotteville-lès-Rouen, France, 76300